Obinutuzumab
Update Venetoclax in CLL
(Update) Acalabrutinib in CLL and MCL
Zanubrutinib
NCCN Guidelines for Patients for CLL
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
UpToDate
Cancer.gov